No short-term immunological effects of Pneumococcus vaccination in patients with systemic lupus erythematosus

References

• Iliopoulos AG, Tsokos GC. Immunopathogenesis and spec-trum of infections in systemic lupus erythematosus. Semin Arthritis Rheum 1996;25:31 8–36.
   Google Scholar
• Davies KA, Beynon HLC, Walport MJ. Consider profilaxis in systemic lupus erythematosus (letter). Br Med J 1994;308:133 .
   PubMedGoogle Scholar
• Rubin LA, Urowitz MB, Gladman DD. Mortality in systemic lupus erythematosus: The bimodal pattern revisited. Q J Med 1985;55:87–98.
   Google Scholar
• Petri M, Genovese M. Incidence of and risk factors for hospitalization in systemic lupus erythematosus: A prospective study of the Hopkins lupus cohort. J Rheumatol 1992;19: 1559–65.
   PubMed Web of Science ®Google Scholar
• Pistiner M, Wallace DJ, Nessim S, Metzger AL, Klinenberg JR. Lupus erythematosus in the 1980s: A survey of 570 patients. Semin Arthritis Rheum 1991;21:5 5–64.
   Google Scholar
• Zimmermann-Nielsen E, Baatrup G, Thorlacius-Ussing O, Agnholt J, Svehag SE. Complement activation mediated by mannan-binding lectin in plasma from healthy individuals and from patients with SLE, Crohn's disease and colorectal cancer. Suppressed activation by SLE plasma. Scand J Immunol 2002;55:10 5–10.
   Google Scholar
• Garred P, Voss A, Madsen HO, Junker P. Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients. Genes Immun 2001;2:442–50.
   PubMed Web of Science ®Google Scholar
• Shoenfeld Y, Aron-Maor A. Vaccination and autoimmunity - "Vaccinosis": A dangerous liaison? J Autoimmun 2000;14: 1–10.
   PubMed Web of Science ®Google Scholar
• Older SA, Battafarano DF, Enzenauer RJ, Krieg AM. Can immunization precipitate connective tissue disease? Report of five cases of systemic lupus erythematosus and review of the literature. Semin Arthritis Rheum 1999;29:13 1–9.
   PubMedGoogle Scholar
• Rose NR. Immunologic hazards associated with vaccination of humans. J Autoimmun 2000;14:11–3.
   PubMed Web of Science ®Google Scholar
• Kowal C, Weinstein A, Diamond B. Molecular mimicri between bacterial and self antigen in a patient with systemic lupus erythematosus. Eur J Immunol 1999;29:190 1–11.
   Google Scholar
• Gross K, Combe C, Kruger K, Schattenkirchner M. Arthritis after hepatitis B vaccination. Report of three cases. Scand J Rheumatol 1995;24:5 0–2.
   Google Scholar
• Shapiro ED, Clemens JD. A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections. Ann Intern Med 1984;101:325–30.
   PubMed Web of Science ®Google Scholar
• Lipnick RN, Karsh J, Stahl NI, Blackwelder WC, Schiffmann G, Klippel JH. Pneumococcal immunization in patients with systemic lupus erythematosus treated with immunosuppres-sives. J Rheumatol 1985;12:111 8–21.
   Google Scholar
• Butler JC, Breimen RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA 1993;270:182 6–31.
   Google Scholar
• Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Mor Morbid Wkly Rep 1997;46:1–24.
   PubMedGoogle Scholar
• Fine MJ, Smith MA, Carson CA, Meffe F, Sankey SS, Weissfeld LA, et al. Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials. Arch Intern Med 1994;154:2666–77.
   PubMed Web of Science ®Google Scholar
• Robertson JD, Nagesh K, Jowitt SN, Dougal M, Anderson H, Mutton K, et al. Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influ-enzae type B in patients with multiple myeloma. Br J Cancer 2000;82:126 1–5.
   PubMedGoogle Scholar
• Hartkamp A, Mulder AH, Rijkers GT, van Velzen-Blad H, Biesma DH. Antibody responses to pneumococcal and haemophilus vaccinations in patients with B-cell chronic lymphoid leukaemia. Vaccine 2001;19:167 1–7.
   Google Scholar
• Croft SM, Schiffman G, Snyder E, Herrmann K, James K, Jarrett MP. Specific antibody response after in vivo antigenic stimulation in systemic lupus erythematosus. Lupus 1993; 4:227–31.
   Google Scholar
• Klippel JH, Karsh J, Stahl NI, Decker JL, Steinberg AD, Schiffman G. A controlled study of pneumococcal polysac-charide vaccine in systemic lupus erythematosus. Arthritis Rheum 1979;22:132 1–5.
   PubMedGoogle Scholar
• Battafarano DF, Battafarano NJ, Larsen L, Dyer PD, Older SA, Muehlbauer S, et al. Antigen-specific antibody responses in lupus patients following immunization. Arthritis Rheum 1998;41:182 8–34.
   Google Scholar
• Bruyn GAW, van Furth R. Pneumococcal polysaccharide vaccines: Indications, efficacy and recommendations. Eur J Clin Microbiol Infect Dis 1991;10:897–910.
   PubMed Web of Science ®Google Scholar
• Jarrett MP, Schiffman G, Barland P, Grayzel Al. Impaired response to pneumococcal vaccine in systemic lupus erythe-matosus. Arthritis Rheum 1980;23:128 7–93.
   Google Scholar
• Obaro S, Henderson DC, Monteil M. Monitor antibody levels after vaccination (letter). Br Med J 1994;308:33 8–9.
   Google Scholar
• McDonald E, Jarratt MP, Schiffman G, Grayzel Al. Persistence of pneumococcal antibodies after immunization in patients with systemic lupus erythematosus. J Rheumatol 1984;11:306–8.
   PubMed Web of Science ®Google Scholar
• Tan EM, Cohen AS, Fries JF. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:127 1–7.
   Google Scholar
• Hochberg MC. Updating the American College of Rheuma-tology revised criteria for the classification of systemic lupus erythematosus ((letter). Arthritis Rheum 1997;40:1725.
   PubMed Web of Science ®Google Scholar
• Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest Suppl 1968; 97:77–108.
   PubMedGoogle Scholar
• Sipka S, Dey I, Buda Cs, Csongor J, Szegedi Gy, Farkas T. The mechanism of inhibitory effect of eicosapentaenoic acid on phagocytic activity and chemotaxis of human neutrophil granulocytes. Clin Immunol Immunopathol 1996;79:22 4–8.
   Google Scholar
• Boswell J, Schur PH. Monocyte function in systemic lupus erythematosus. Clin Immunol Immunopathol 1989;52:27 1–8.
   PubMedGoogle Scholar
• Al-Hadithy H, Isenberg DA, Addison IE, Goldstone AH, Snaith ML. Neutrophil function in systemic lupus erythema-tosus and other collagen diseases. Ann Rheum Dis 1982; 41:33–8.
   Google Scholar
• The risk of vaccination - The importance of "negative" studies (editorial). N Engl J Med 2001;344:372–3.
   PubMedGoogle Scholar
• Aharon-Maor A, Shoenfeld Y. The good, the bad and the ugly of vaccination. IMA J Math Appl Med Biol 2000;2: 225–7.
   Google Scholar
• Gyimesi E, Kavai M, Kiss E, Csipo I, Szucs G, Szegedi Gy. Triggering of respiratory burst by phagocytosis in monocytes of patients with systemic lupus erythematosus. Clin Exp Immunol 1993;94:14 0–4.
   Google Scholar
• Liu MA. Vaccines in the 21th century. Br Med J 1999;319: 1–4.
   PubMedGoogle Scholar
• Spratt BG, Greenwood BM. Prevention of pneumococcal disease by vaccination: does serotype replacement matter? (commentary). Lancet 2000;356:121 0–1.
   Google Scholar
• Fattom A, Lue C, Szu SC, Mestecky J, Schiffman G, Bryla D, et al. Serum antibody response in adult volunteers elicited by injection of Streptococcus pneumoniae type 12F polysacchar-ide alone or conjugated to Diphtheria toxoid. Infect Immun 1990;58:230 9–12.
   Google Scholar
• Powers DC, Anderson EL, Lottenbach K, Mink CM. Reactogenicity and immunogenicity of a protein-conjugate pneumococcal oligosaccharide vaccine in older adults. J Infect Dis 1996;173:101 4–8.
   Google Scholar